No Data
Has Sinotherapeutics Inc.'s (SHSE:688247) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
Xuantai Pharmaceutical (688247.SH): Has not yet deployed Deepseek.
On March 10, Glonghui reported that Xuantai Pharmaceutical (688247.SH) stated on the interactive platform that the company has not yet deployed Deepseek and is still in the stage of understanding and learning. The company continues to pay attention to the application of new AI technologies in technological innovation, product development, and Operation management, and conducts in-depth research to assist the company in better development in the future.
Xuantai Pharmaceutical (688247.SH): Qihe Entrepreneurship has cumulatively reduced its shareholding in the company by 1.7145%.
Xuantai Pharmaceutical (688247.SH) announced that the company received a document issued by Qihe Venture on March 6, 2025...
Xuantai Pharmaceutical: 2024 Annual Results Express Announcement
2024 Annual Results Express Announcement
Xuantai Pharmaceutical (688247.SH): Qihe and Chuangye together reduced their Shareholding by 575,200 shares.
Xuantai Pharmaceutical (688247.SH) released an announcement stating that Shareholder Qi He Chuang Ye will... on January 21, 2025.